| GRANT | DATE | AMOUNT | PROGRAM |
|---|---|---|---|
|
Children's Hospital Corporation
Advancing the development of a novel implantable Glucose Responsive Glucagon (GRG) delivery system |
01.09.2025 | $4,007,100.00 | Type 1 Diabetes, Improve Outcomes |
|
United States African Development Foundation
Malawi Livelihood Improvement Project (MLIP) Phase II |
11.05.2024 | $4,500,000.00 | Type 1 Diabetes, Improve Outcomes |
|
American Diabetes Association, Inc.
2025-2027 Type 1 Diabetes Camp Initiative |
11.05.2024 | $1,440,780.00 | Type 1 Diabetes, Improve Outcomes |
|
Michigan State University
A c-peptide complex for improved glucose metabolism in people with type 1 diabetes |
10.09.2024 | $2,111,881.00 | Type 1 Diabetes, Prevent & Delay |
|
Diabetes Australia
Improvements in outcomes for young people with diabetes in less-resourced countries, through geographic expansion and country-specific data-driven initiatives |
10.09.2024 | $4,299,165.00 | Type 1 Diabetes, Improve Outcomes |
|
Jaeb Center For Health Research Foundation, Inc.
CGM for the early detection and management of dysglycemia in pregnancy (IMAGINE) |
09.24.2024 | $3,577,428.00 | Type 1 Diabetes, Improve Outcomes |
|
University of Washington
Pathogenic action of autoantibodies on islet function and viability in type 1 diabetes |
09.10.2024 | $770,000.00 | Type 1 Diabetes, Prevent & Delay |
|
The Regents of the University of Colorado, Denver
Epigenomic biomarkers of the incomplete maternal protection in type 1 diabetes |
09.10.2024 | $940,010.00 | Type 1 Diabetes, Prevent & Delay |
|
American Camping Association, Inc.
ACA Professional Development 2024-2027 |
09.10.2024 | $180,809.00 | Type 1 Diabetes, Improve Outcomes |
|
Board of Trustees of the Leland Stanford Junior University
Development of a molecular switch based continuous insulin sensor |
08.27.2024 | $4,000,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
GPPAD Coordination Center Continuation 2025-2029 |
08.27.2024 | $4,866,895.00 | Type 1 Diabetes, Prevent & Delay |
|
Benaroya Research Institute at Virginia Mason
Mechanisms of autoantibody reversion in at-risk subjects |
08.27.2024 | $1,078,203.00 | Type 1 Diabetes, Prevent & Delay |
|
Trustees of Indiana University
The Finding Immune Nascent Diabetes (FIND-T1D) |
08.13.2024 | $1,088,662.00 | Type 1 Diabetes, Prevent & Delay |
|
Boston Medical Center Corporation
Supplemental funding for an effectiveness trial to support adoption of AID in underserved adults with T1D |
07.24.2024 | $900,100.00 | Type 1 Diabetes, Improve Outcomes |
|
Mass General Brigham for the Brigham and Women's Hospital
U.S. Preventive Type 1 Diabetes Coalition |
07.24.2024 | $1,762,259.00 | Type 1 Diabetes, Prevent & Delay |
|
Université libre de Bruxelles
Studying the selective β cell sensitivity to a homozygous PD-L1 mutation in neonatal diabetes |
07.24.2024 | $430,517.00 | Type 1 Diabetes, Prevent & Delay |
|
Sanford World Clinics
Program DeteKtA: Detecting type 1 diabetes and preventing diabetic ketoacidosis (DKA) |
07.24.2024 | $317,880.00 | Type 1 Diabetes, Prevent & Delay |
|
Mass General Brigham for the Brigham and Women's Hospital
Accelerating progress and promoting quality T1D care for the poorest billion through the global PEN-Plus Partnership |
07.24.2024 | $23,998,776.00 | Type 1 Diabetes, Improve Outcomes |
|
Washington University
Preclinical Development to advance a T1D antigen-specific immunotherapy called SAgA-T1D |
07.09.2024 | $2,591,258.00 | Type 1 Diabetes, Prevent & Delay |
|
The Regents of the University of Colorado, Denver
ASK the Experts 2024 |
07.09.2024 | $1,499,993.00 | Type 1 Diabetes, Prevent & Delay |
|
Prev
12...46
Next
1 - 20 of 909 results
|
|||